This page lists all pharmaceutical reports related to the field of Cancer Immunotherapy. The reports include market research reports and pipeline analyses.
Displaying 151 - 189 of 189 results
- Vaccine antigen delivery technologies - Molecular systems to open new markets
- New Approaches to Pharma Research and Development: Evolving strategies to rejuvenate Research and Development efficiency
- World Market for Cancer Therapeutics and Biotherapeutics
- Biosimilars and Follow-On Biologics Report: The Global Outlook 2009-2024
- Key Trends In Drug-diagnostic Co-development: Identifying collaborative opportunities and navigating regulatory challenges
- Accelerating Lead Generation: Emerging technologies and strategies
- Monoclonal Antibodies in Cancer Therapy 2009-2024
- Monoclonal Antibody Therapeutics 2009-2024
- Innovations in Oncology Diagnostics: Technological advances, growth opportunities and future market outlook
- Launching Next Generation Oncology Products: Evolving Strategies in a Payor’s Market
- The World Market for Biosimilars and the Potential for US Follow-on Biologics
- Global Pharmaceutical Biotech Market 2010-2025
- Pipeline Insight: Breast Cancer - Recent approvals increase pressure on pipeline candidates
- Lung Cancer Therapeutics Market Outlook and Pipeline Analysis
- Pipeline Insight: Biologic Targeted Cancer Therapies - Next generation jostles for market position
- Cancer Therapeutics: Market Insight and R&D Pipeline Analysis
- Therapeutic Vaccines - A far-off promise of greatness
- Non-Hodgkin's Lymphomas Diffuse large B-cell lymphoma and follicular lymphoma
- Molecular Diagnostics in Cancer Testing
- Pipeline Insight: Therapeutic Cancer Vaccines - Prospect of first approval set to reinvigorate interest from major companies
- The Worldwide Market for Cancer Diagnostics - 2010
- The Future of Monoclonal Antibodies - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis
- The Future of Oncology Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis
- The Future of Biosimilars - Market Forecasts to 2015, Opportunity Analysis and Regulatory Pathways
- The Future of Orphan Disease Therapeutics - Market Forecasts to 2015, Pipeline Analysis and Reimbursement
- Biomarkers in Drug Discovery - Optimizing Drug Discovery Timeline and Costs
- Top 10 Biotechnology Companies - SWOT Analysis, Competitive Benchmarking, Financial Analysis and R&D Pipeline
- Small and Medium Biopharmaceutical Enterprises in North America and Europe - Biotechnology Clusters, Funding Characteristics and Regulatory Landscape
- Ribonucleic Acid (RNA) Therapeutics - Strong Potential to Address Unmet Needs in Pharma
- Biomarkers in Breast Cancer, 2010
- Personalized Medicine 2010: Assessing the Opportunities and Challenges in Commercializing Companion Diagnostics and Targeted Therapies
- Oncology Market Leaders – Analyses and Outlook – 2010-2025
- Melanoma - Drug Pipeline Analysis and Market Forecasts to 2015
- Non-Small-Cell Lung Cancer (NSCLC) - Drug Pipeline Analysis and Market Forecasts to 2015
- Non-Hodgkin's Lymphoma (NHL) - Drug Pipeline Analysis and Market Forecasts to 2015
- Prostate Cancer - Drug Pipeline Analysis and Market Forecasts to 2015
- The Top 10 Biosimilar Players: Positioning, Performance and SWOT Analyses
- World Pharmaceutical and Biopharmaceutical Market, 2010-2015 (Pipeline Analysis of the Top 50 Companies)
- Pricing and Reimbursement Strategies for Diagnostics: Overcoming reimbursement issues and navigating the regulatory environment